Exabis Library
Welcome to the e-CCO Library!
P388: Shear wave elastography predicts short-term response to induction therapy in patients with Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P389 Post induction infliximab trough levels predict long-term endoscopic remission in paediatric patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P389: Efficacy and safety of ustekinumab in patients with Crohn’s disease refractory to anti-tumour necrosis factor: real clinical practice
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P389: Efficacy of once a day multi matrix mesalamine formulation, lialda in patients with active mild to moderate ulcerative colitis after inadequate response to the pH-dependent release mesalamine formulation, asacol
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P389: Indicators for inadequate response to advanced therapy in patients with Ulcerative Colitis: results from a medical chart review in the United Kingdom
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P389: Low-dose metronidazole is associated with a decreased rate of endoscopic recurrence of Crohn's disease after ileal resection
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P389: Switching infliximab to subcutaneous from intravenous therapy (SWIMSUIT) – A prospective, real-world, single centre, phase IV interventional study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P389: Systematic review and meta-analysis of risk factors for recurrent primary sclerosing cholangitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P389: The value of oxidative stress parameters to predict histological severity in ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P390 New features of molecular diagnostics of the regulation of molecular apoptotic pathway in ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P390: Diverting Loop Ileostomy in Medically Refractory Crohn's Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P390: Efficacy and safety of mesenchymal stem cell therapy with darvadstrocel for complex perianal fistulizing Crohn´s disease: multicentric experience in the Basque Country and Navarre
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P390: Methotrexate is not superior to placebo in maintaining remission in patients with ulcerative colitis: results from the MERIT-UC study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P390: Open-label study to evaluate the pharmacokinetics of fidaxomicin in inflammatory bowel disease patients with Clostridium difficile infection (the PROFILE study): pharmacokinetics analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P390: The impact of anti-TNF therapy in adjuvant setting on postoperative recurrence patterns over decades in complicated Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P390: To double dose or not to double dose? That is the question: Single centre experience in the use of infliximab antibodies and levels in a paediatric IBD (pIBD) cohort
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P390: Ustekinumab modulates IL-12 and IL-23-related cell type-specific inflammatory transcriptional states in Ulcerative Colitis induction therapy
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P391 Side-to-side strictureplasty and its modification over the ileocecal valve for extensive Crohn’s ileitis: single-centre long-term outcome
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P391: Antibiotics in pediatric Inflammatory Bowel Diseases: a systematic review
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P391: Are cut-off ranges of Infliximab serum levels in Crohn’s disease always the same in clinical practice?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM